MindMaze

Office Hours #1: The benefits of the MindMotion GO teleconsultation feature

Replay episode #1 of our ‘Office Hours with MindMaze’ event as we talk through the  benefits of teleconsultation with...

JNP Podcast

MindMaze’s Dr. John Krakauer joins the Journal of Neurophysiology Podcast to discuss ‘Neuroscene’ – a new essay-based content type.

Podcast: Our Chief Medical and Scientific Advisor, Dr. John Krakauer, joins the JNP podcast (of which he’s the Associ...

Sifted

The healthtech trends of 2021 – in six charts

From greater integration of healthtech to its five key subsectors, we’ve read the latest Dealroom report on hea...

Multiple Sclerosis News Today

MindMaze’s therapeutic games opening to more neurologic patients

MindMaze’s animated ‘games,’ designed to aid in recovering motor and cognitive skills in people with neurological dis...

The Jist

The science of learning and gamifying neurological repair and rehab

Our Chief Medical and Scientific Advisor, Dr John Krakauer, recently joined ‘Chatter’ podcast host Josh Hamilton to d...

Health Tech World

MindMaze expecting ‘exceptional growth’ with product portfolio

Neurotherapeutics devices company MindMaze Healthcare has announced its commercial product portfolio and clinical pip...

CTA

Beyond Definitions: Future Standards for Digital Therapeutics

In 2020, CTA launched a new initiative to develop standards for the use of digital therapeutics — an emerging field t...

MindMaze

MindMaze Expands Global Reach of Digital Neurotherapeutics Portfolio with Four New Partnerships

Bringing the future of brain repair for stroke, Parkinson’s, and other neurological conditions to patients in&n...